Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.8%1-day move

₹67.50

prior close

₹66.98

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0-0.8-1.8-3.7-11.0-2.4+2.2+16.6+15.6+32.5+27.4

Up moveDown movePending

AI summary

Bal Pharma Limited has informed the exchanges (NSE and BSE) that the trading window for its securities will be closed for designated persons and their immediate relatives starting 1st April 2026. The window will remain shut until 48 hours after the declaration of the audited financial results for the quarter and financial year ending 31st March 2026. The exact date of the board meeting to approve these results will be communicated separately. This is a routine compliance filing under SEBI's insider trading regulations.

Likely market impact

This is a standard regulatory disclosure with no direct impact on shareholders. It signals that the company's FY26 audited results are imminent, which could be a material event for investors to watch for in the coming weeks.